Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Operational Other
confidence 75%
filed 2026-09-01
Item 8.01
Alumis announced topline results from its Phase 2b LUMUS trial of envudeucitinib for systemic lupus erythematosus (SLE). The trial did not meet its primary and secondary endpoints in the overall population, but showed robust responses in a prespecified IFNGS-high subgroup, supporting Phase 3 development. This is a material clinical development milestone for a late-stage biopharmaceutical company's lead program, affecting investor assessment of pipeline progress and regulatory pathway, though it does not fit neatly into earnings, M&A, impairment, or other specific event categories.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-09-01
EX-99.1
GFL Environmental announced the closing of its acquisition of SECURE Waste Infrastructure Corp., financed through a combination of revolving credit capacity, issuance of 75.1 million subordinate voting shares, and a new US$1 billion senior secured term loan. The transaction materially expands GFL's scale and is expected to accelerate achievement of multi-year financial targets outlined at investor day in early 2025. This is a completed material acquisition meeting the definition of ma_activity under Item 1.01/2.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-09-01
Item 1.01
Caterpillar entered into three material credit facilities totaling $11.5 billion in aggregate commitments: a new 364-Day Facility ($3.5 billion), an amended Three-Year Facility ($3.0 billion), and an amended Five-Year Facility ($5.0 billion), materially expanding the company's liquidity and borrowing capacity.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 89%
filed 2026-09-01
Item 1.01
Caterpillar Financial Services Corporation entered into three material credit facilities totaling $11.5 billion in aggregate commitments: a new 364-Day Facility ($3.5 billion), an amended and extended Three-Year Facility ($3.0 billion through August 2029), and an amended and extended Five-Year Facility ($5.0 billion through August 2031). These unsecured revolving credit arrangements with specific financial covenants represent the creation of new direct financial obligations and amendments to existing credit agreements.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-01
Item 3.02
Andalusian Credit Company issued 4,638,462 shares of LLC interests for $71.1 million on August 28, 2026, pursuant to a capital drawdown notice under subscription agreements with investors. The sale is explicitly exempt from Securities Act registration under Section 4(a)(2) and Regulation D, making this a classic unregistered private placement. The substantial capital raise and dilutive equity issuance to accredited investors is material to investors assessing the company's capitalization and ownership structure.
View raw filing on EDGAR →
8-K
Cybersecurity Incident
confidence 95%
filed 2026-09-01
Item 1.05
The filing explicitly discloses unauthorized access to the Company's computer network on August 28, 2026, with possible compromise of patient data (personal and protected health information). The Company is treating this as a reportable event and has engaged external cybersecurity and forensic specialists. While no material operational disruption has occurred to date, the disclosure of unauthorized network access involving potential patient data constitutes a material cybersecurity incident under Item 1.05, required since 2023.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-09-01
Item 5.02
The disclosure centers on an amendment to Thomas P. Tulaney's Supplemental Executive Retirement Plan Agreement (SERP), modifying the terms of his retirement benefit by adding an annuity-funded continuation provision. This is a compensatory arrangement modification for a named executive officer, fitting the exec_compensation category. While Tulaney is described as "former President," the material event is the modification to his compensation/retirement benefits, not his departure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-01
Item 5.02
An Nuyttens has been appointed President of Mohawk's Flooring Rest of the World segment, effective mid-October 2026. The appointment emphasizes her 30+ years of international leadership experience and the strategic importance of this segment to the company's long-term growth.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-09-01
Item 7.01
McEwen Inc. announced that its 46.3%-owned subsidiary McEwen Copper Inc. closed a $240 million senior secured 4-year term loan facility with a syndicate of lenders. This represents creation of a new direct financial obligation for the subsidiary, with proceeds designated for advancing the Los Azules copper project and general corporate purposes. While the debt is technically at the subsidiary level, McEwen's significant ownership stake (46.3%) and the material impact on the Los Azules project—a key asset for McEwen—make this a material disclosure for the parent company's investors.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-09-01
Mr. Johnson Lau, Vice President of Finance, resigned effective August 31, 2026. The filing explicitly discloses the departure of a principal officer and confirms the Board's acceptance of the resignation. The Finance VP role is a material executive position whose departure would affect investor assessment of the company's financial oversight and stability.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-01
Item 7.01
The disclosure reports completion of an acquisition by Tutsi, S.A. de C.V. (a Tootsie Roll subsidiary) of The Klass Company's confectionery business in Mexico, including the Winis brand. This constitutes a material acquisition that expands the company's Mexico confectionery portfolio alongside the existing Tutsi Pop brand, meeting the definition of M&A activity under Item 1.01/2.01 standards.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-01
Item 2.01
Ryman Hospitality Properties completed its acquisition of the JW Marriott Orlando Grande Lakes Resort and The Ritz-Carlton Orlando, Grande Lakes for approximately $1.38 billion, funded through a registered public offering of 5.865 million shares and $700 million in senior notes. The transaction materially expands the company's hospitality portfolio.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-09-01
EX-99.1
ASUR announced the closing of its acquisition of Motiva's entire equity interest in CPC for R$5.1 billion (US$992.2 million), adding 20 airports across Brazil, Ecuador, Costa Rica, and Curaçao to its portfolio. The press release explicitly states this "represents a key component of ASUR's growth strategy" and was financed through a loan facility, indicating a material M&A transaction that would significantly affect investor assessment of the company's size, geographic footprint, and financial position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-01
Item 8.01
Barinthus Biotherapeutics plc's Scheme of Arrangement with Clywedog Therapeutics, Inc. was sanctioned by the High Court on September 1, 2026, and is expected to become effective on September 9, 2026, resulting in a change of control and delisting of the company's ADSs from Nasdaq.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-01
Item 8.01
This disclosure concerns the extension of exchange offers for Qorvo's senior notes in connection with Skyworks' previously announced merger with Qorvo. The filing explicitly states that "Each Exchange Offer is conditioned upon the closing of the transactions pursuant to which Qorvo will merge with and into a subsidiary of Skyworks" and references the Form S-4 registration statement filed in connection with the Mergers. While the immediate Item 8.01 event is the extension of the expiration date (a procedural matter), the substantive disclosure centers on the ongoing material acquisition activity—the merger of Qorvo into Skyworks and the related debt exchange offers. The filing repeatedly emphasizes the Mergers as the principal transaction and notes Skyworks' hope to close "within the calendar year," confirming this is part of a material change-of-control transaction.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-09-01
EX-99.1
Søren Steenberg Jensen assumed the role of Chief Executive Officer on 1 September 2026, succeeding Mikael Øpstun Skov. The company stated the appointment will not change strategy or operating mode.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-09-01
EX-99.2
Mikael Øpstun Skov was appointed as a Director of Hafnia Limited, effective from the Extraordinary General Meeting on 23 September 2026, following his departure as Chief Executive Officer. The Nomination Committee emphasized his instrumental role in establishing the Company's strategic direction and extensive institutional knowledge.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-01
Item 2.01
Crinetics Pharmaceuticals completed a merger transaction in which it became a wholly owned subsidiary of Parent for approximately $10.0 billion in aggregate consideration, resulting in a change of control. At the Effective Time, all Company Common Stock was converted into merger consideration, all directors resigned, all officers were removed, and the company's certificate of incorporation and bylaws were amended. Multiple agreements including equity plans and a sales agreement were terminated in connection with the merger consummation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-01
Item 5.02
The Board of Directors appointed Zane Nielsen as Chief Accounting Officer and Corporate Controller effective September 1, 2026, replacing Richard Hoffman in the principal accounting officer role. This is a material executive appointment to a key financial leadership position, supported by detailed biographical information and compensation terms ($350,000 base salary, 50% bonus target, 60% LTI target).
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-09-01
Aegon has published the agenda for an Extraordinary General Meeting (EGM) scheduled for October 8, 2026, to seek shareholder approval for redomiciliation from Bermuda to the US. While this is technically a notice of a forthcoming shareholder vote rather than results of a completed vote, the redomiciliation represents a material change of control and governance structure that would substantially affect investor assessment. The disclosure of the EGM agenda and shareholder materials constitutes a material governance event requiring shareholder approval, classified as shareholder_vote_results under the taxonomy's governance domain, though the vote itself has not yet occurred.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-01
This press release announces positive Phase III trial results for remibrutinib (REMODEL-1/-2 trials) in relapsing multiple sclerosis, demonstrating superiority versus teriflunomide on primary and key secondary endpoints with a favorable safety profile. While the disclosure involves clinical trial progress toward a potential new indication, it does not constitute an earnings release (no financial results), executive change, M&A activity, or other discrete event types. The announcement of significant clinical trial success that supports future regulatory submission and commercialization is a material operational/strategic milestone for a pharmaceutical company, warranting classification as an operational event rather than a more specific category.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-01
The 6-K discloses Shell plc's application for admission of 228,003,843 new ordinary shares to the London Stock Exchange, explicitly stating these shares "will be issued by the Company as part of the consideration for the Company's acquisition of ARC Resources Ltd." This is a material acquisition transaction with a significant equity component, meeting the definition of ma_activity under Items 1.01 or 2.01.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-09-01
Item 8.01
The filing discloses that Royale Energy has regained current SEC reporting status after previously being delinquent, trading has resumed on OTC Pink, and the company has initiated an OTCQB application. While the core event—restoration of reporting compliance and trading resumption—is primarily a governance/regulatory matter affecting market access and investor visibility, the disclosure also references an ongoing strategic review with a financial advisor. The materiality stems from the company's return to compliance and restoration of trading, which directly affects shareholder access to the security and the company's capital markets position.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-01
EX-99.1
The exhibit discloses that Nasdaq has granted Alpha Compute an additional 180-day compliance period (until March 1, 2027) to regain compliance with the minimum bid price requirement of $1.00 per share. The company was previously notified on March 2, 2026 that its stock had traded below $1.00 for 30 consecutive business days. This is a material delisting risk disclosure under Item 3.01 equivalent, as the company faces potential delisting if it fails to achieve the required minimum bid price during the compliance period.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-01
EX-99
Elbit Systems announced the signing of contracts valued at approximately $270 million for advanced ISR & Targeting payloads to be performed over up to six years. This is a material contract award in the company's core defense technology business. While the disclosure does not fit the specific categories of earnings release, M&A activity, or debt issuance, it represents a significant operational and commercial milestone—a major customer contract that would affect a reasonable investor's assessment of the company's revenue pipeline and growth prospects. The contract value and multi-year duration make this material to investors evaluating the company's business performance and backlog.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-01
EX-99.1
This press release announces RedHill's acquisition of exclusive commercialization rights to Ferring's Rebyota® and Clenpiq® for a $12 million upfront payment plus tiered royalties and potential milestones. The transaction is explicitly described as "transformational" and represents a material strategic repositioning of RedHill's commercial GI business, funded by the previously announced $18 million Talicia divestiture. The acquisition of revenue-generating FDA-approved products materially expands RedHill's commercial portfolio and liquidity position, meeting the definition of material M&A activity under Item 1.01/2.01.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-09-01
This 6-K furnishes a supplemental report on a dividend distribution of approximately $75 million previously announced on August 5, 2026. The filing specifies the per-share dividend amounts in USD ($0.05811) and ILS (ILS 0.1750273), record date (September 2, 2026), payment date (September 16, 2026), and applicable withholding tax rates for different shareholder categories. This is a material capital distribution to shareholders that would affect investor assessment of the company's capital allocation and cash position.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-01
EX-99.1
Quantum BioPharma announces a voluntary delisting of its Class B shares from the Canadian Securities Exchange (CSE), effective September 4, 2026. While characterized as voluntary and intended to consolidate trading on Nasdaq, this is a material change in listing status that affects shareholder trading options, liquidity, and market access. The disclosure explicitly identifies risks including reduced trading volume, liquidity, and analyst coverage, as well as potential impacts on resale exemptions and the company's ability to complete private placements—all factors a reasonable investor would consider when assessing the registrant's capital-raising ability and share liquidity.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-01
Item 1.01
Revolution Medicines entered into four material lease agreements on August 27, 2026 for approximately 672,000 square feet of space in Redwood City, California to serve as its new headquarters, involving substantial financial commitments including approximately $2.7 million in monthly base rent at full commencement, $23.1 million in rent abatement, and $115.9 million in tenant improvement allowances.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-01
EX-99.2
Baidu announced the effective conversion of its secondary listing status on the Hong Kong Stock Exchange to a dual primary listing status, becoming a dual primary listed company on both the Hong Kong Stock Exchange and Nasdaq, with ordinary shares and ADSs remaining fungible. This material capital-markets and listing-status event affects the registrant's trading structure and investor access.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-01
EX-99.1
This exhibit is a monthly vehicle delivery announcement disclosing August 2026 results (39,107 vehicles, up 4% YoY), the debut of the G9L model, and progress on autonomous vehicle testing in Guangzhou. While it contains operational metrics and product milestones, it does not constitute a formal earnings release (which would include comprehensive financial statements or quarterly results) nor a periodic financial report. The disclosure is material to investors assessing the company's operational performance and market position, but the event type is operational rather than financial, as it focuses on delivery volumes, product launches, and regulatory milestones rather than financial results.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-01
Item 8.01
Upstream Bio announced pivotal Phase 3 development plans for verekitug in severe asthma and CRSwNP following FDA End-of-Phase 2 meetings, including a 400mg every 12-week dosing regimen, trial design with approximately 1,500 patients across both indications, and planned Q1 2027 initiation with potential BLA submission and launch as early as 2030. This represents a material clinical development milestone with significant implications for the drug's regulatory pathway and commercial potential.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-01
Item 5.02
Marc Elia, the Company's Chairman, was appointed as Chief Executive Officer effective August 30, 2026, assuming the principal executive officer role previously held by William Duke, Jr. The appointment includes compensatory arrangements including a base salary of $750,000, target bonus of 70%, stock option grant of 10.7 million shares, and sign-on bonus of $500,000.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-09-01
Item 7.01
Yum China issued an interim report for the six months ended June 30, 2026, disclosing financial results for the period. Although filed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 2.02, the substance is an earnings release — a periodic financial results disclosure material to investors' assessment of the company's performance and financial condition.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-01
EX-99.1
This is an operational disclosure of material business metrics for OwlPay Harbor, the Company's core fintech payment platform. The exhibit reports August 2026 operating metrics showing significant month-over-month growth: annualized payment volume nearly tripled to approximately US$255 million (from US$93 million in July), payment volume increased 174.6%, and contracted enterprise clients grew to 84. While not a discrete event like M&A or an executive change, the substantial and consistent operational scaling of the Company's primary revenue-generating platform—described as "the seventh consecutive month-over-month increase"—would materially affect a reasonable investor's assessment of the registrant's business trajectory and financial prospects. This is operational performance disclosure rather than a periodic financial report or earnings release.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-09-01
Item 8.01
Strategy Inc's board declared cash dividends on multiple series of preferred stock (STRF, STRE, STRK, STRD, and STRC) payable on September 30, 2026 and October 15, 2026, and maintained the 12.00% dividend rate on the Variable Rate Series A Perpetual Stretch Preferred Stock.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-01
Item 1.01
Chesapeake Utilities sold a 49% minority interest in the Florida Energy Pathway project to NextEra Energy Resources, with Chesapeake retaining 51% ownership and establishing a joint venture governed by an Amended and Restated LLC Agreement dated August 28, 2026. This material transaction involves a ~$1.2 billion infrastructure project and represents a significant capital deployment and change in the ownership and governance structure of a major strategic asset.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-01
Item 7.01
Graco announced the completion of its acquisition of Valco Melton for $447 million in cash on August 31, 2026. The acquisition was previously announced on May 21, 2026, and this 8-K discloses the closing of the transaction. This is a material M&A event involving a significant cash outlay and strategic expansion into adhesive application and quality assurance technologies, affecting the registrant's capital allocation and business scope.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-09-01
Item 2.01
NCS Multistage Holdings completed a merger in which its common stock was converted into ordinary shares of Parent at specified exchange ratios, with stockholder approval obtained via written consent on May 31, 2026, and the Effective Time occurring on or before September 1, 2026. The company became a wholly owned subsidiary of Parent, resulting in a change of control. The merger completion triggered delisting from Nasdaq, termination of the credit agreement, extinguishment of common equity rights, and replacement of the entire board and management team.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-01
Item 5.03
Amendments to the certificate of incorporation and bylaws of NCS Multistage Holdings were adopted pursuant to the Merger Agreement at the Effective Time, reflecting structural changes to the company's governing documents following the merger completion.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-09-01
The 6-K announces the appointment of Andreas Tolpeit as Chief Financial Officer and member of the executive committee, effective September 1, 2026. While the filing also mentions the departure of Jany Fruytier as CFO, the principal disclosed action is Tolpeit's appointment to a named executive officer role. CFO appointments are material to investors as they affect financial oversight and strategy execution.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-01
Item 5.07
This is a disclosure of voting results on a material matter submitted to security holders. The Fund's members voted on the deemed assignment of the investment management agreement in connection with the planned merger of Equitable Holdings and Corebridge Financial. The consent solicitation expired on August 27, 2026, and the filing reports that all 50,066,325 units voted in favor (100% approval), with no votes against or abstentions. This is a classic Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-09-01
Item 8.01
Public Storage completed its acquisition of PS Canada Holdings, LLC for approximately $1.2 billion in upfront consideration (consisting of ~$900 million in PSA OP Units and ~$310 million in cash), plus up to $288 million in contingent earn-out consideration based on NOI performance targets. The transaction adds 68 self-storage facilities with 5.3 million net rentable square feet across major Canadian markets and is expected to be accretive to the company's long-term IRR, NOI growth, and FFO per share.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-01
Item 8.01
BioMarin completed the acquisition of Alesta Therapeutics B.V. via a share purchase transaction on August 31, 2026, making Alesta a wholly owned subsidiary. This is a material acquisition disclosed under Item 8.01 (Other Events) as a completion of a previously announced M&A transaction, consistent with the ma_activity event type covering entry into, completion, or termination of material acquisitions.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-01
Item 7.01
Comstock has entered into a letter of intent with SOCAR for a $1.65 billion transaction involving the sale of working interests in upstream assets (20% of Legacy Haynesville, 15% of Western Haynesville) and a 15% stake in Pinnacle Gas Services LLC midstream subsidiary. This constitutes a material disposition/partial sale of assets and represents a significant capital transaction that would materially affect the registrant's financial position and asset base, with explicit mention of reducing net debt from $3.1 billion to $1.5 billion pro forma.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-01
Item 8.01
Victory Capital Holdings, Inc. has entered into a definitive agreement to acquire 100% of First Eagle Investments for approximately $7.0 billion in total consideration, with closing expected in Q1 2027. This is a material acquisition that will result in First Eagle's investment adviser and subadviser becoming indirect wholly-owned subsidiaries of Victory Capital, creating a combined entity with approximately $571 billion in total client assets. The transaction is clearly a material M&A activity under Item 8.01 disclosure.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-01
Item 6.02
This disclosure reports a change of special servicer under the Pooling and Servicing Agreement, effective September 1, 2026, whereby C-IV Asset Management LLC assumed all duties and responsibilities from Greystone Servicing Company LLC. While Item 6.02 is not a named event type in the taxonomy, the change of a servicer is a governance matter affecting the administration and oversight of the securitized mortgage pool. The filing includes detailed information about C-IV AM's qualifications, ratings, experience, and portfolio, indicating materiality to certificateholders' interests in the trust's performance and management.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This disclosure reports a change of special servicer under the Pooling and Servicing Agreement for CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-C2, effective September 1, 2026. Greystone Servicing Company LLC transferred its special servicing division assets to C-IV Asset Management LLC, which assumed all duties and responsibilities as special servicer. While Item 6.02 is titled "Change of Servicer or Trustee," this is fundamentally a governance/operational change affecting the administration and oversight of the trust's mortgage loan portfolio. The disclosure is material because it affects the entity responsible for managing approximately $20.7 billion in aggregate principal balance across 60 transactions, including special servicing of approximately $2.1 billion in actively serviced assets. The change involves continuity of key personnel and detailed representations regarding C-IV AM's qualifications, ratings, and track record, indicating this is a significant administrative transition for certificateholders.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of special servicer under the Pooling and Servicing Agreement: Greystone Servicing Company LLC transferred its special servicing division assets to C-IV Asset Management LLC effective September 1, 2026. While the filing provides extensive operational and financial details about C-IV AM's qualifications, experience, and portfolio, the core event is a governance/administrative change in the servicer role. This is material to certificateholders as the special servicer manages problem loans and workout strategies affecting pool performance, though it is not a departure or appointment of an individual executive but rather a change in the servicing entity itself.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This disclosure reports a change of servicer effective September 1, 2026, whereby C-IV Asset Management LLC assumed the special servicing duties previously held by Greystone Servicing Company LLC across multiple CMBS pools, including three specific mortgage loans held by the Issuing Entity (Crocker Park, 132 West 27th Street, and Plaza America). The filing explicitly invokes Item 6.02 (Change of Servicer or Trustee) and details the successor servicer's qualifications, ratings, and portfolio. While servicer changes are governance/administrative in nature, this particular transition is material because it affects the management and workout of approximately $20.7 billion in assets across 60 transactions, with $2.1 billion actively in special servicing as of June 30, 2026.
View raw filing on EDGAR →